Skip to main content
. 2021 Aug 31;13(8):e17613. doi: 10.7759/cureus.17613

Table 5. Relations between study variables.

The table shows the relations between different variables and their statistical significances, whether they are statistically significant or not.

  Hb during treatment p-value
Anemia Normal
n % n %
Tumor type
   Ovarian cancer 39 84.8% 7 15.2% 0.543
   Endometrial cancer 29 93.5% 2 6.5%
   Cervical cancer 21 95.5% 1 4.5%
   Uterine cancer 2 100.0% 0 0.0%
   Other 6 100.0% 0 0.0%
Histopathology type
   Squamous 14 93.3% 1 6.7% 0.935
   Adenocarcinoma 32 88.9% 4 11.1%
   Other 28 93.3% 2 6.7%
   Unknown 23 88.5% 3 11.5%
Lymph node involvement
   No 19 86.4% 3 13.6% 0.014
   Clinical 1 100.0% 0 0.0%
   Surgical 5 83.3% 1 16.7%
   Imaging 23 95.8% 1 4.2%
   Lymphovascular space 0 0.0% 2 100.0%
   Unknown 49 94.2% 3 5.8%
Bowel resection
   Yes 2 66.7% 1 33.3% 0.257
   No 95 91.3% 9 8.7%
BSO
   Yes 44 88.0% 6 12.0% 0.291
   No 53 93.0% 4 7.0%
Omentectomy
   Yes 16 84.2% 3 15.8% 0.255
   No 80 92.0% 7 8.0%
TAH
   Yes 46 88.5% 6 11.5% 0.336
   No 51 92.7% 4 7.3%
Other
   Yes 16 94.1% 1 5.9% 0.505
   No 81 90.0% 9 10.0%
Cancer stage
   1A 7 100.0% 0 0.0% 0.490
   1B 9 90.0% 1 10.0%
   1C 1 100.0% 0 0.0%
   2A 4 100.0% 0 0.0%
   2B 10 90.9% 1 9.1%
   2C 1 100.0% 0 0.0%
   3A 4 100.0% 0 0.0%
   3B 10 100.0% 0 0.0%
   3C 23 76.7% 7 23.3%
   4A 3 100.0% 0 0.0%
   Unknown 25 96.2% 1 3.8%
Cancer grade
   IA 2 100.0% 0 0.0% 0.939
   IB-1 1 100.0% 0 0.0%
   IB-2 3 100.0% 0 0.0%
   IIA 6 100.0% 0 0.0%
   IIIA 9 90.0% 1 10.0%
   IIIB 2 100.0% 0 0.0%
   IVA 11 100.0% 0 0.0%
   IVB 8 88.9% 1 11.1%
   Unknown 55 87.3% 8 12.7%